The latest biotech news

News and Trends 29 Jan 2020

Oxitec Unveils First Field Trial Results for Crop-Protecting GM Moths

A study led by Oxitec has shown for the first time that diamondback moths genetically engineered to produce only male offspring can survive in the wild, a solution that shows promise for cutting populations of the crop pest. Caterpillars of the diamondback moth Plutella xylostella are one of the most destructive pests for growers of […]

January 29, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 28 Jan 2020

A Future Gene Therapy Could Be Delivered in Tiny ‘Nanocontainers’

A Swiss research group has developed tiny plastic particles that could carry gene therapies to the center of the cell with less risk of getting attacked by the immune system than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient […]

January 28, 2020 - 3 minutesmins - By Jonathan Smith

cancer vaccine cancer immunotherapy ervaxx

News and Trends 27 Jan 2020

UK Startup Snaps up Potential Universal Cancer Immunotherapy

The cancer vaccine developer Ervaxx has licensed a preclinical-stage ‘universal’ cancer immunotherapy based on the recent discovery of a new strain of immune T-cells at Cardiff University, UK. Last week, a team led by researchers at Cardiff University published research about T-cells capable of hunting a wide range of cancers including leukemia and melanoma. Experiments […]

January 27, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 24 Jan 2020

Broad Institute Loses Appeal on European CRISPR Patent

A decision from the Boards of Appeal at the European Patent Office has revoked the claim of the Broad Institute to general patents on CRISPR/Cas9 gene editing technology, strengthening the position of its opponent UC Berkeley in Europe. The Broad Institute in Cambridge, US, is one of the main contenders in the ongoing battle for […]

January 24, 2020 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 24 Jan 2020

€6M Seed Round to Develop First Urine Test for Kidney Cancer

The Swedish biotech Elypta has raised a seed round worth €6.1M to fund a clinical trial of a urine test for signs of recurrent kidney cancer, which could improve patient follow-up after surgery. The seed round was led by the Swedish VC firm Industrifonden. Other investors in the round included the VC impact fund of […]

January 24, 2020 - 3 minutesmins - By Jonathan Smith

brain cancer glioblastoma divide and conquer

News and Trends 23 Jan 2020

Merck Spinout Bags €15M Series A to Tackle Cancer and Fibrosis

iOnctura, a spinout from Merck KGaA, has raised €15M to take its cancer and fibrosis drugs to phase I clinical trials. The Series A round was co-led by new investors INKEF Capital and VI Partners. The founding investor of iOnctura, M Ventures — the corporate venture arm of Merck — also contributed to the round, […]

January 23, 2020 - 2 minutesmins - By Jonathan Smith

thyroid eye disease graves disease horizon therapeutics

News and Trends 22 Jan 2020

FDA Greenlights First Treatment for Rare Autoimmune Eye Disease

An antibody drug developed by the Irish biopharma Horizon Therapeutics has been approved by the FDA for the treatment of adults with the rare autoimmune condition thyroid eye disease. The approval of the drug came ahead of schedule, with the decision originally expected in March. The drug, a monoclonal antibody, is branded as Tepezza. Thyroid […]

January 22, 2020 - 2 minutesmins - By Jonathan Smith

pdcLine Pharma dendritic cell cancer vaccine

News and Trends 22 Jan 2020

Off-The-Shelf Lung Cancer Vaccine Clinical Trial Gets €20M Boost

The French-Belgian company PDC*Line Pharma has raised a €20M Series B round to fund an ongoing phase I/II trial of its off-the-shelf therapeutic vaccine for lung cancer. The total €20M consists of €13.9M in equity investments and €6.1M in loans and subsidies from the Walloon Region of Belgium. PDC*Line’s current investors took part in the […]

January 22, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 21 Jan 2020

T-Cell Discovery Could Herald Universal Cancer Immunotherapy

An international research team has found a new type of T-cell that could lead to cell immunotherapies able to treat cancers beyond the reach of current CAR T-cell therapies. Market-approved CAR T-cell therapies including Yescarta and Kymriah have revolutionized cancer treatment by modifying immune T-cells to hunt down cancer cells. However, these treatments are only […]

January 21, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 21 Jan 2020

German Biotech Raises €11M to Regenerate Liver Damage

Biotech company HepaRegeniX has raised a Series B round that will allow its first candidate drug for liver disease to enter clinical trials later this year. Based in Tübingen, Germany, HepaRegenix was founded in 2017 with a €9M Series A round. The same investors are now taking part in a Series B round […]

January 21, 2020 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Jan 2020

Medical Gel Prepares to Enter Clinical Trials for Replacing Corneal Transplants

An international collaboration involving researchers in Europe, Asia, and North America has begun preparations for testing in humans a therapeutic gel that could replace the need for corneal transplants for the treatment of blindness. Corneal transplants are the most common treatment for blindness caused by corneal injury. However, donor shortages and high costs make it […]

January 20, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 18 Jan 2020

DNA Data Storage Project Receives €20.7M from US Intelligence Agency

A DNA data storage project, involving French biotech DNA Script, has been awarded a contract worth up to €20.7M from the US Intelligence Advanced Research Projects Activity agency to develop a prototype instrument able to store and retrieve 1 terabyte of information in 24 hours. The Molecular Encoding Consortium, led by Robert Nicol at the Broad […]

January 18, 2020 - 3 minutesmins - By External Contributor

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Oxitec Unveils First Field Trial Results for Crop-Protecting GM Moths

A Future Gene Therapy Could Be Delivered in Tiny ‘Nanocontainers’

UK Startup Snaps up Potential Universal Cancer Immunotherapy

Broad Institute Loses Appeal on European CRISPR Patent

€6M Seed Round to Develop First Urine Test for Kidney Cancer

Merck Spinout Bags €15M Series A to Tackle Cancer and Fibrosis

FDA Greenlights First Treatment for Rare Autoimmune Eye Disease

Off-The-Shelf Lung Cancer Vaccine Clinical Trial Gets €20M Boost

T-Cell Discovery Could Herald Universal Cancer Immunotherapy

German Biotech Raises €11M to Regenerate Liver Damage

Medical Gel Prepares to Enter Clinical Trials for Replacing Corneal Transplants

DNA Data Storage Project Receives €20.7M from US Intelligence Agency

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!